UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
February 8, 2024 4:30 P.M.
Form:
S-1
CIK:
0001971532
Company Name:
Telomir Pharmaceuticals, Inc.
File Number:
333-275534